Remote Ischemic Conditioning: The Commercial Market: LifeCuff Perspective. (September 2017)

• Record Type: Journal Article
• Authors: Garratt, Kirk N.; Leschinsky, Boris
• Other Names: Przyklenk Karin guest-editor.; Whittaker Peter guest-editor.
• Is Part Of: Journal of cardiovascular pharmacology and therapeutics. Volume 22:Number 5(2017:Sep.)
• Page Start: 408
• Page End: 413
• Publication Date: 2017-09
• Subjects: remote ischemic conditioning -- ischemic heart disease -- devices -- clinical outcomes; Cardiovascular pharmacology -- Periodicals; Cardiovascular system -- Diseases -- Treatment -- Periodicals; 616
• DOI: 10.1177/1074248417715003
• Languages: English
• ISSNs: 1074-2484

Abstract

Although remote ischemic conditioning promises significant benefit to patients with a variety of acute and chronic illnesses, development of automated, clinically applicable devices has been slow. At least 3 small companies have launched efforts to develop useful tools intended for sale in European and North American markets. The market challenges and opportunities linked to the development of a cost-effective, reliable, and clinically effective device for the application of remote ischemic conditioning are presented in this article.